Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Cindy L Hovington & Martin Lepage. (2012) Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia. Expert Review of Neurotherapeutics 12:1, pages 53-69.
Read now
Read now
Basant K Puri. (2011) Brain tissue changes and antipsychotic medication. Expert Review of Neurotherapeutics 11:7, pages 943-946.
Read now
Read now
WilliamT. Carpenter$suffix/text()$suffix/text(). (2011) Criticism of the DSM-V risk syndrome: A rebuttal. Cognitive Neuropsychiatry 16:2, pages 101-106.
Read now
Read now
Nora S Vyas, Sanjiv Kumra & Basant K Puri. (2010) What insights can we gain from studying early-onset schizophrenia? The neurodevelopmental pathway and beyond. Expert Review of Neurotherapeutics 10:8, pages 1243-1247.
Read now
Read now
Articles from other publishers (28)
Şükrü Kartalcı, Mehmet Fatih Erbay, Ayşegül Kahraman, Fatih Çandır & Lale Gönenir Erbay. (2021) Evaluation of CSF flow dynamics in patients with schizophrenia using phase-contrast cine MRI. Psychiatry Research 304, pages 114172.
Crossref
Crossref
Helle G. Andersen, Jayachandra M. Raghava, Claus Svarer, Sanne Wulff, Louise B. Johansen, Patrick K. Antonsen, Mette Ø. Nielsen, Egill Rostrup, Anthony C. Vernon, Lars T. Jensen, Lars H. Pinborg, Birte Y. Glenthøj & Bjørn H. Ebdrup. (2020) Striatal Volume Increase After Six Weeks of Selective Dopamine D2/3 Receptor Blockade in First-Episode, Antipsychotic-Naïve Schizophrenia Patients. Frontiers in Neuroscience 14.
Crossref
Crossref
Elisabetta Caletti & Francesca Siri. 2019. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches. Clinical Cases in Psychiatry: Integrating Translational Neuroscience Approaches
259
276
.
Adriana ForteaDaniel IlzarbeLaura EspinosaMireia SolerdelcollClara de CastroGiovanni OrioloGisela SugranyesInmaculada Baeza. (2018) Long-Acting Injectable Atypical Antipsychotic Use in Adolescents: An Observational Study. Journal of Child and Adolescent Psychopharmacology 28:4, pages 252-257.
Crossref
Crossref
Ezgi İnce & Alp Üçok. (2017) Relationship Between Persistent Negative Symptoms and Findings of Neurocognition and Neuroimaging in Schizophrenia. Clinical EEG and Neuroscience 49:1, pages 27-35.
Crossref
Crossref
Sarah LytleMolly McVoyMartha Sajatovic. (2017) Long-Acting Injectable Antipsychotics in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology 27:1, pages 2-9.
Crossref
Crossref
Emilie Leclerc, Cristiano Noto, Rodrigo A. Bressan & Elisa Brietzke. (2015) Determinants of adherence to treatment in first-episode psychosis: a comprehensive review. Revista Brasileira de Psiquiatria 37:2, pages 168-176.
Crossref
Crossref
Ashwini Rajasekaran, Ganesan Venkatasubramanian, Michael Berk & Monojit Debnath. (2015) Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications. Neuroscience & Biobehavioral Reviews 48, pages 10-21.
Crossref
Crossref
Rachel L.C. Mitchell & Susan L. Rossell. (2014) Perception of emotion-related conflict in human communications: What are the effects of schizophrenia?. Psychiatry Research 220:1-2, pages 135-144.
Crossref
Crossref
Else-Marie Løberg, Siri Helle, Merethe Nygård, Jan Øystein Berle, Rune A. Kroken & Erik Johnsen. (2014) The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability. Frontiers in Psychiatry 5.
Crossref
Crossref
Zhi Yang, Yong Xu, Ting Xu, Colin W. Hoy, Daniel A. Handwerker, Gang Chen, Georg Northoff, Xi-Nian Zuo & Peter A. Bandettini. (2014) Brain Network Informed Subject Community Detection In Early-Onset Schizophrenia. Scientific Reports 4:1.
Crossref
Crossref
Mark J. Millan, Kevin Fone, Thomas Steckler & William P. Horan. (2014) Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment. European Neuropsychopharmacology 24:5, pages 645-692.
Crossref
Crossref
Elaine F. Walker, Hanan D. Trotman, Sandra M. Goulding, Carrie W. Holtzman, Arthur T. Ryan, Allison McDonald, Daniel I. Shapiro & Joy L. Brasfield. (2013) Developmental mechanisms in the prodrome to psychosis. Development and Psychopathology 25:4pt2, pages 1585-1600.
Crossref
Crossref
Chiara Chiapponi, Fabrizio Piras, Federica Piras, Sabrina Fagioli, Carlo Caltagirone & Gianfranco Spalletta. (2013) Cortical Grey Matter and Subcortical White Matter Brain Microstructural Changes in Schizophrenia Are Localised and Age Independent: A Case-Control Diffusion Tensor Imaging Study. PLoS ONE 8:10, pages e75115.
Crossref
Crossref
C.W. Holtzman, H.D. Trotman, S.M. Goulding, A.T. Ryan, A.N. MacDonald, D.I. Shapiro, J.L. Brasfield & E.F. Walker. (2013) Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience 249, pages 172-191.
Crossref
Crossref
Hanan D. Trotman, Carrie W. Holtzman, Arthur T. Ryan, Daniel I. Shapiro, Allison N. MacDonald, Sandra M. Goulding, Joy L. Brasfield & Elaine F. Walker. (2013) The development of psychotic disorders in adolescence: A potential role for hormones. Hormones and Behavior 64:2, pages 411-419.
Crossref
Crossref
Arnold E. Eggers. (2013) A serotonin hypothesis of schizophrenia. Medical Hypotheses 80:6, pages 791-794.
Crossref
Crossref
Mark J. Millan. (2013) An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy. Neuropharmacology 68, pages 2-82.
Crossref
Crossref
Nenad Vasic, Bernhard J. Connemann, Robert C. Wolf, Hayrettin Tumani & Johannes Brettschneider. (2011) Cerebrospinal fluid biomarker candidates of schizophrenia: where do we stand?. European Archives of Psychiatry and Clinical Neuroscience 262:5, pages 375-391.
Crossref
Crossref
Joseph T. Coyle & Glenn T. Konopaske. 2012. Basic Neurochemistry. Basic Neurochemistry
1000
1011
.
Rubén Antonio Vázquez-Roque, Brenda Ramos, Carolina Tecuatl, Ismael Juárez, Anthony Adame, Fidel de la Cruz, Sergio Zamudio, Raúl Mena, Edward Rockenstein, Eliezer Masliah & Gonzalo Flores. (2012) Chronic administration of the neurotrophic agent cerebrolysin ameliorates the behavioral and morphological changes induced by neonatal ventral hippocampus lesion in a rat model of schizophrenia. Journal of Neuroscience Research 90:1, pages 288-306.
Crossref
Crossref
Sheena Waters-Metenier & Timothea Toulopoulou. (2011) Putative structural neuroimaging endophenotypes in schizophrenia: a comprehensive review of the current evidence. Future Neurology 6:5, pages 679-715.
Crossref
Crossref
David J. Bond, Donna J. Lang, Melissa M. Noronha, Mauricio Kunz, Ivan J. Torres, Wayne Su, William G. Honer, Raymond W. Lam & Lakshmi N. Yatham. (2011) The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania. Biological Psychiatry 70:4, pages 381-387.
Crossref
Crossref
Annapaola Prestia, Marina Boccardi, Samantha Galluzzi, Enrica Cavedo, Andrea Adorni, Andrea Soricelli, Matteo Bonetti, Cristina Geroldi, Panteleimon Giannakopoulos, Paul Thompson & Giovanni Frisoni. (2011) Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia. Psychiatry Research: Neuroimaging 192:2, pages 77-83.
Crossref
Crossref
Nora S. Vyas, Neva H. Patel & Basant K. Puri. (2011) Neurobiology and phenotypic expression in early onset schizophrenia. Early Intervention in Psychiatry 5:1, pages 3-14.
Crossref
Crossref
Anca R. Rădulescu. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume I. Handbook of Schizophrenia Spectrum Disorders, Volume I
187
217
.
Brian Dean, Andrew Gibbons, Elizabeth Scarr & Elizabeth A. Thomas. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume I. Handbook of Schizophrenia Spectrum Disorders, Volume I
237
251
.
Trevor Archer, Richard M. Kostrzewa, Richard J. Beninger & Tomas Palomo. (2010) Staging Perspectives in Neurodevelopmental Aspects of Neuropsychiatry: Agents, Phases and Ages at Expression. Neurotoxicity Research 18:3-4, pages 287-305.
Crossref
Crossref